"Advancements in Wilson's Disease Treatment: A Market Analysis"
Wilson's disease is a rare genetic disorder that affects the body's ability to metabolize copper, leading to its accumulation in various organs, especially the liver and brain. The treatment landscape for Wilson's disease has seen significant advancements in recent years, offering hope to those affected by this condition. One of the mainstays of Wilson's disease treatment market is copper-chelating agents, such as penicillamine and trientine. These medications work by binding to excess copper in the body and facilitating its removal through urine. They can help control copper levels and prevent further damage to the liver and other organs. In cases where copper-chelating agents are not effective or tolerated, liver transplantation becomes a crucial option. Liver transplantation is a life-saving procedure that replaces the damaged liver with a healthy one, effectively curing the disease. However, it's considered a last resort due to the associated risks and li...